MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Dopaminergic reconfiguration of an inverted network hierarchy in Parkinson’s disease

    Z. Zhang, T. Feng (Beijing, China)

    Objective: To determine how acute dopaminergic treatment reshapes large-scale brain network organization in Parkinson’s disease (PD). Background: Dopamine replacement reliably improves motor symptoms in PD,…
  • 2026 International Congress

    Synchronous Unilateral Pendular Nystagmus and Palatal Myoclonus After Pontine Hemorrhage: A Case Report

    J. Cruz, J. Ong, C. Diesta, P. Cataniag (Makati City, Philippines)

    Objective: To present a post-stroke pontine bleed patient who developed a rare movement disorder with a treatment approach. Background: A 43-year-old male presented with involuntary…
  • 2026 International Congress

    Relationship Between Perceived and Actual Gluteal Muscle Activation in Parkinson’s Disease

    K. Kakegawa, T. Matsuda, J. Ogawa, Y. Soutome (Bunkyo-ku, Japan)

    Objective: To examine the relationship between the subjective sense of gluteal activation and actual muscle activity during a quadruped hip extension task in individuals with…
  • 2026 International Congress

    Investigating the role of ATP7B heterozygous variants in Parkinson’s Disease

    P. Mitrotti, M. Avenali, P. Dimartino, R. Minardi, G. Pisano, I. Palmieri, A. Fiorentino, L. Malfer, M. Khani, P. Reyes, G. Cossu, V. Carelli, EM. Valente (Pavia, Italy)

    Objective: WD often includes parkinsonism and copper dysregulation is implicated in Parkinson’s disease (PD), we investigated whether heterozygous ATP7B variants are associated with increased PD…
  • 2026 International Congress

    Seven-Year Outcome of Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson’s Disease Patients

    M. Nassar, I. Senderova, M. Katson, A. Sinai, I. Schlesinger (Haifa, Israel)

    Objective: To assess 7-year outcomes of unilateral MRI-guided focused ultrasound (MRgFUS) ventral intermediate nucleus thalamotomy in tremor-dominant Parkinson’s disease (TDPD) patients with levodopa-unresponsive tremor, and…
  • 2026 International Congress

    Subthalamic low-frequency activity reflects engagement during live sports viewing

    S. Falciglia, L. Caffi, F. Luiso, C. Palmisano, A. Mazzoni, I. Isaias (Pontedera, Italy)

    Objective: To investigate subthalamic nucleus (STN) low-frequency dynamics during emotional engagement while watching live sports in patients with Parkinson's disease treated with adaptive deep brain…
  • 2026 International Congress

    Genetic Architecture Of Intracranial Brain Calcification: A Systematic Review

    S. Bandrivska, M. Bandrivskyi, T. Slobodin, H. Houlden, F. Magrinelli (London, United Kingdom)

    Objective: To systematically identify monogenic disorders associated with intracranial intraparenchymal brain calcification and synthesise their clinical, radiological and molecular features. Background: Brain calcification is a…
  • 2026 International Congress

    Allied Health Professionals in Movement Disorders: a survey of clinical practice and education needs across the world

    A. Sivaramakrishnan, A. Roberts, E. Tripoliti, L. Rochester, A. Nieuwboer, J. Dean (San Antonio, TX, USA, USA)

    Objective: To understand the breadth and scope of clinical practice and education needs of the Allied Health Professionals (AHP) involved in the care of Patients…
  • 2026 International Congress

    Association Between Liver Function and Motor Symptoms in Parkinson’s Disease: A Cross-cohort Analysis of Chinese and PPMI patients

    Y. Wang, X. Zheng, X. Liu, C. Li (Chengdu, China)

    Objective: This study aimed to compare liver function profiles between Chinese PD patients and an international cohort from Parkinson’s Progression Markers Initiative (PPMI), and to…
  • 2026 International Congress

    Phase 1 Study of BT-267, a potent, selective, brain-penetrant, and oral small molecule inhibitor of LRRK2

    T. Dam, D. Hilt, E. Remeeva, A. Mathias, M. Mcgill, K. Dokukina, A. Pushechnikov, R. Karapetyan, V. Kazey, I. Dukes, N. Savchuk (Dover, USA)

    Objective: The aim of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BT-267 in healthy adults. Background: Leucine rich repeat kinase…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley